Humimab-HC 40 Injection Substitute
RXCipla Ltd
₹18000
(₹14760.0 per unit)
RXAlkem Laboratories Ltd
₹9374
(₹19216.75/ 1ml)
RXIpca Laboratories Ltd
₹25000
(₹20500.0 per unit)
RXHetero Drugs Ltd
₹23437.5
(₹24023.5/ 1ml)
RXTricept Life Sciences Pvt Ltd
₹26000
(₹26650.0/ 1ml)
RXRPG Life Sciences Ltd
₹28351.5
(₹29060.25/ 1ml)
RXAbbott India Ltd
₹21825
(₹54562.5/ 1ml)

Composition:
ADALIMUMAB-40MG
Uses:
Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, Plaque psoriasis, Crohn’s disease, Uveitis, Ulcerative colitis.
Medicinal Benefits:
Humimab-HC 40 Injection consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.
Humimab-HC 40 Injection contains Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive.
Humimab-HC 40 Injection affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis or abnormal liver enzymes. Humimab-HC 40 Injection can also increase the risk of developing cancers; hence, informing your doctor if you have a history of any cancer is essential.